Tag Archives: Biosimilar Market

Biosimilars are nearly identical versions of biologic medicines (complex drugs derived from living organisms) designed to treat a range of chronic and critical conditions, from cancer to autoimmune diseases. They offer comparable efficacy, safety, and quality to their reference products but come at a fraction of the cost. Unlike traditional …

Read More »